Locally Advanced Hepatocellular Carcinoma
Drug | Drug Name | Drug Description |
---|---|---|
DB09035 | Nivolumab | A PD-1 blocking antibody used to treat melanoma, non small-cell lung cancer, renal cell cancer, head and neck cancer, and Hodgkin lymphoma. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB09035 | Nivolumab | Programmed cell death protein 1 | target |
DB09035 | Nivolumab | Programmed cell death 1 ligand 1 | target |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB11595 | Atezolizumab | 1 | Not Yet Recruiting | 1 |
DB08875 | Cabozantinib | 1 | Completed | 1 |
DB00531 | Cyclophosphamide | 1 | Recruiting | 1 |
DB11714 | Durvalumab | 1 | Recruiting | 1 |
DB09035 | Nivolumab | 1 | Completed | 1 |
DB09037 | Pembrolizumab | 1 | Recruiting | 1 |
DB00020 | Sargramostim | 1 | Recruiting | 1 |
DB11771 | Tremelimumab | 1 | Recruiting | 1 |
DB11595 | Atezolizumab | 2 | Not Yet Recruiting | 1 |
DB11595 | Atezolizumab | 2 | Recruiting | 2 |
DB11595 | Atezolizumab | 2 | Withdrawn | 1 |
DB00112 | Bevacizumab | 2 | Not Yet Recruiting | 1 |
DB00112 | Bevacizumab | 2 | Recruiting | 1 |
DB08875 | Cabozantinib | 2 | Recruiting | 1 |
DB08875 | Cabozantinib | 2 | Withdrawn | 1 |
DB06186 | Ipilimumab | 2 | Recruiting | 1 |
DB09078 | Lenvatinib | 2 | Recruiting | 1 |
DB09035 | Nivolumab | 2 | Recruiting | 1 |